[Betaserc in the treatment of vestibular disorders in vascular dystonia syndrome].
Putilina
M V
MV
Kuznetsova
Iu I
IuI
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001007:Anxiety / Q000175:diagnosis / Q000209:etiology / Q000523:psychology; D003863:Depression / Q000175:diagnosis / Q000209:etiology / Q000523:psychology; D004422:Dystonia Musculorum Deformans / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D012720:Severity of Illness Index; D018434:Sickness Impact Profile; D011795:Surveys and Questionnaires; D015837:Vestibular Diseases / Q000150:complications* / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta